Association between non‐alcoholic fatty liver disease with the susceptibility and outcome of COVID‐19: a retrospective study
G Wang, S Wu, C Wu, Q Zhang, F Wu… - Journal of Cellular …, 2021 - Wiley Online Library
This study aims to evaluate the effect of non‐alcoholic fatty liver disease (NAFLD) on the
susceptibility and consequences of coronavirus disease 2019 (COVID‐19). We …
susceptibility and consequences of coronavirus disease 2019 (COVID‐19). We …
Mendelian randomization analysis reveals no causal relationship between nonalcoholic fatty liver disease and severe COVID-19
J Li, A Tian, H Zhu, L Chen, J Wen, W Liu… - Clinical Gastroenterology …, 2022 - Elsevier
Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has witnessed
more than 4.5 million deaths as of the time of writing. Whether nonalcoholic fatty liver …
more than 4.5 million deaths as of the time of writing. Whether nonalcoholic fatty liver …
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study
M Mahamid, W Nseir, T Khoury… - European Journal of …, 2021 - journals.lww.com
Aim Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was
declared a pandemic by WHO in 2020. Obesity and other components of the metabolic …
declared a pandemic by WHO in 2020. Obesity and other components of the metabolic …
[HTML][HTML] Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, affecting all the …
syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, affecting all the …
[HTML][HTML] Effect of nonalcoholic fatty liver disease (NAFLD) on COVID-19: A single-center study of 3983 patients with review of literature
Background The presence of metabolic syndrome (MS) is associated with increased
disease severity in patients with coronavirus disease 2019 (COVID-19). Non-alcoholic fatty …
disease severity in patients with coronavirus disease 2019 (COVID-19). Non-alcoholic fatty …
[HTML][HTML] Non-alcoholic fatty liver disease (NAFLD) and COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression
A Kurniawan, TI Hariyanto - Narra J, 2023 - ncbi.nlm.nih.gov
It is important to identify risk factors for poor outcomes of coronavirus disease 2019 (COVID-
19) patients. Currently, the correlation between non-alcoholic fatty liver disease (NAFLD) …
19) patients. Currently, the correlation between non-alcoholic fatty liver disease (NAFLD) …
[HTML][HTML] Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
P Anirvan, SP Singh, A Giammarino… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic has swept through nations,
crippled economies and caused millions of deaths worldwide. Many people diagnosed with …
crippled economies and caused millions of deaths worldwide. Many people diagnosed with …
NAFLD and COVID-19: a pooled analysis
S Sachdeva, H Khandait, J Kopel, MM Aloysius… - SN comprehensive …, 2020 - Springer
The earliest evidence from China suggested that COVID-19 patients are even more
vulnerable to succumbing from complications in the presence of a multimorbid status …
vulnerable to succumbing from complications in the presence of a multimorbid status …
[PDF][PDF] Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis
D Ji, E Qin, J Xu, D Zhang, G Cheng, Y Wang, G Lau - J Hepatol, 2020 - afef.asso.fr
Methods From January 20 through February 18, 2020, consecutive patients admitted to two
designated COVID-19 Hospitals in China with confirmed COVID-19 and NAFLD status …
designated COVID-19 Hospitals in China with confirmed COVID-19 and NAFLD status …
[HTML][HTML] Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
CG Dietrich, A Geier, U Merle - World journal of gastroenterology, 2023 - ncbi.nlm.nih.gov
The pandemics of coronavirus disease 2019 (COVID-19) and non-alcoholic fatty liver
disease (NAFLD) coexist. Elevated liver function tests are frequent in COVID-19 and may …
disease (NAFLD) coexist. Elevated liver function tests are frequent in COVID-19 and may …